IBD Medication Tracker: Connect Dose Dates and Symptoms

An IBD medication tracker should preserve the treatment story around each dose. People with Crohn's disease or ulcerative colitis may use oral, rectal, injected, or intravenous medicines, and biologic regimens can change route between induction and maintenance (Crohn's & Colitis Foundation). A standard reminder can tell you that a dose is due. A useful IBD timeline also records when it happened, whether the schedule changed, what you noticed afterward, and what questions need to reach your gastroenterology team.

Build the tracker from the prescribed schedule

Begin with the schedule supplied by your prescriber and the medication's current prescribing information. Record the medication name, dose, route, planned date, actual date, and the person or clinic responsible for administering it. Some IBD biologics use different induction and maintenance routes. For example, the FDA label for risankizumab in Crohn's disease specifies intravenous induction at weeks 0, 4, and 8 followed by subcutaneous maintenance beginning at week 12 (FDA prescribing information). This example shows why a generic repeating reminder may be too simple. Your tracker should reflect your own prescription and any clinician-directed interval or route change. Add the prescribing clinic's contact details and the pharmacy or infusion-center information needed to resolve a scheduling problem.

Record the actual dose and its context

Mark a dose complete when it is actually taken or administered. If an infusion moves, an injection is late, or a dose is missed, preserve both the scheduled and actual dates. Add a short note about the reason without rewriting the prescription yourself. For injections, a site record can help you follow the rotation instructions provided for your medication. For infusions and injections, record any observation you want to discuss, including the timing and duration. The Crohn's & Colitis Foundation notes that biologics may be delivered by injection or intravenous infusion and can be associated with injection-site or infusion-site reactions (IBD medication overview). Contact your clinical team for advice about concerning symptoms rather than relying on the tracker to classify them. A photo or long narrative is rarely necessary for every routine dose, so decide in advance which fields are required.

Connect symptoms to dose dates carefully

A dose-linked timeline can reveal a sequence worth discussing, such as the same symptom returning before several scheduled doses. The record should show your usual baseline, the symptom, its severity, the dose date, and relevant objective results. A repeating pattern supports a clearer question but does not identify the cause or justify changing treatment (AGA therapeutic drug monitoring guideline). The American Gastroenterological Association recommends reactive therapeutic drug monitoring for adults with active IBD treated with anti-tumor necrosis factor therapy, and the guideline defines active disease using symptoms confirmed by objective biochemical, endoscopic, or radiologic evidence (AGA therapeutic drug monitoring guideline). Drug levels, antibodies, biomarkers, imaging, and endoscopy require clinical interpretation.

Design reminders around the points where plans fail

Good reminders address more than the administration time. They can prompt you before a dose, preserve a refill or infusion deadline, and ask for a brief confirmation afterward. Research on adherence interventions in IBD found that educational, behavioral, and multicomponent approaches have been studied, with multicomponent interventions showing the most consistent success across the included studies (systematic review). Another systematic review found uncertain overall evidence that digital IBD tools improve medication adherence compared with usual care (digital health review). A reminder app is therefore an organizational aid. It works best when the prompts match your real barriers and remain easy to maintain. Review quiet hours, escalation settings, and duplicate alerts so useful prompts do not become background noise.

Turn the timeline into a GI-ready summary

Before an appointment, reduce the record to the period relevant to your question. Include planned and actual dose dates, missed or delayed doses, route or interval changes, short tolerability notes, the main symptom trend, and any objective results your team asked you to track. End with one focused question, such as whether a repeated pre-dose pattern needs further assessment. This format separates what happened from what you think it might mean. Keep the full history available, but lead with the shortest date range that shows the pattern clearly. Label gaps instead of filling them from memory.

Aidy supports medication adherence records, biologic induction and maintenance schedules, reminders, injection-site rotation, post-dose check-ins, symptom timelines, and doctor-ready reports in its current iPhone app (Apple App Store). Set up the prescribed schedule first, then use the tracker to create an accurate treatment history for your next clinical conversation. The goal is a record you can maintain between visits and summarize quickly when a decision is approaching.